To include your compound in the COVID-19 Resource Center, submit it here.

Victrelis boceprevir: Phase III data

A pre-specified analysis of 912 patients with chronic HCV genotype 1 infection enrolled in 1 of 3 Phase III trials showed that

Read the full 226 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE